New heart valve device tested for severe aortic stenosis
NCT ID NCT07116551
Summary
This early study is testing the safety and basic function of Abbott's new balloon-expandable TAVI system. The device is designed to replace a narrowed aortic valve in patients with severe, symptomatic aortic stenosis. The study involves a small group of participants to see if the device can be successfully delivered and works as intended.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Clinique Pasteur Toulouse
Toulouse, Midpyre, 31076, France
-
Columbia University Medical Center/New York-Presbyterian
New York, New York, 10032, United States
-
Montefiore Medical Center - Moses Division
The Bronx, New York, 10461, United States
-
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States
Conditions
Explore the condition pages connected to this study.